Ticlopidine

CONCLUSION : Ticlopidine is effective for treating acute cerebral infraction and decreasing the rate of platelet aggregation .

结论：噻氯匹定可用于脑梗死急性期的治疗，抑制血小板聚集是其重要的治疗机制。

Ticlopidine vs aspirin in decreasing blood viscosity and anti_platelet function

噻氯匹定和阿司匹林降低血液粘度和抗血小板作用的比较

The Effect of Ticlopidine on Platelet Aggregation Function and Blood Viscosity

抵克力得对血小板聚集功能及血液流变学的影响

Evaluation of Pharmacological Property and Clinical Application of Ticlopidine and Clopidogrel

噻氯吡定和氯吡格雷的药理学特性与临床应用评价

Study on the Inhibitory Effect of Ticlopidine on Platelet Aggregation

噻氯匹啶对血小板聚集功能的抑制作用研究

OBJECTIVE : To provide information for clinical rational usage of ticlopidine and clopidogrel .

前言：目的：为临床合理使用噻氯吡定和氯吡格雷提供参考。

Effects of ticlopidine on activation of platelet in type 2 diabetes mellitus

噻氯匹定对2型糖尿病病人血小板活化状态的影响

Objective : A HPLC method for quantitative determination of Ticlopidine hydrochloride tablets has been developed .

目的：建立盐酸噻氯匹定片的HPLC含量测定方法。

Observation of Efficacy and Safety of Aspirin and Ticlopidine on Prevention of Acute Cerebral Infarction

阿司匹林与噻氯匹啶预防急性脑梗死的疗效与安全性观察

The Clinic Study of Ticlopidine for Prevention Hypertension and Thrombosis Induced by Recombinant Human Erythropoietin

抵克力得预防重组人类促红细胞生成素诱发顽固性高血压和血栓症的临床研究

Adverse drug reaction during ticlopidine treatment

噻氯匹定的药物不良反应概述

Effects of Ticlopidine and Ligustrazine on Platelet Agglutination in Patients with Ischemic Cerebral Infarction

抵克力得与川芎嗪对缺血性脑卒中血小板聚集性的影响

Application of Clinical for Ticlopidine Inhibiting EDTA-dependent Platelet Aggregation

噻氯匹啶抑制EDTA依赖性血小板聚集在临床中的应用

Effect of ticlopidine on thromboxane B_2 production by platelets

噻氯匹定对血小板血栓烷B2生成的影响

Pharmacokinetics of ticlopidine capsules and tablets in healthy volunteers

抵克力得胶囊及片剂的药动学研究

METHODS : 44 patients with high blood viscosity were treated with ticlopidine in a dose of 250 mg daily for 14 days .

方法：44例高血粘度的2型糖尿病患者口服抵克立得片250mg，qd，疗程2周。

Objective To learn the security of ticlopidine by observing its short-term adverse effect in treating patients with coronary atherosclerotic heart disease .

目的本文观察应用噻氯匹定治疗冠心病中患者的短期不良反应，以了解噻氯匹定的安全性。

AIM : To compare the efficacy and safety of clopidogrel on anti platelet aggregation with ticlopidine .

比较阿司匹林和噻氯匹啶预防脑卒中复发的长期药物经济学效果。

PurposeA high performance liquid chromatography ( HPLC ) method for quantitative determination of Ticlopidine hydrochloride capsules had been developed .

目的建立盐酸噻氯匹定胶囊的高效液相色谱（HPLC）含量测定方法。

Inhibition of Ticlopidine to Thromboxane B_2 in Cerebral Thrombosis

噻氯匹啶对脑血栓病人的血栓烷B2的抑制

Combination of asprin 、 ticlopidine 、 heparin in the prevention of subacute stent thrombosis

阿司匹林、噻氯匹啶、肝素预防冠状动脉支架亚急性血栓形成的效果

Oral administration of ticlopidine had an inhibitory effect on collagen-induced platelet thromboxane B2 ( TXB2 ) production .

口服噻氯匹定（ticlopidine）能抑制胶原诱导的血小板血栓烷B2（TXB2）生成。

It was also shown thai ticlopidine could significantly inhibit platelet TXB2 formation stimulated by adenosine diphosphate ( ADP ) .

噻氯匹定对ADP诱导的血小板TXB2生成也有显著抑制作用。

These results suggested that antiplatelet efficacy of ticlopidine was shown , in part , to inhibit arachidonic acid metabolism of platelets .

噻氯匹定的抗血小板作用至少有部分与抑制花生四烯酸的代谢有关。

Methods : 52 CAD patients with coronary spasm were randomly assigned to receive ticlopidine aspirin or Ticlid for6 months .

方法：对52例冠心病存在冠脉痉挛的患者，随机分为阿司匹林治疗组和抵克力得治疗组。

Conclusion Ticlopidine can prevent EDTA-dependent platelet aggregation , it is very suitable for platelet count of EDTA-clumper in clinical laboratories .

结论噻氯匹啶是一种较强的抗血小板活化药物，对EDTA依赖性血小板聚集有很好的抑制作用，适用于临床血小板的测定。

To observe an efficacy of combination of aspirin , ticlopidine and heparin in the prevention of subacute stent thrombosis ( SST ) .

目的观察阿司匹林、抵克力得和肝素预防亚急性冠状动脉支架血栓形成（SST）的有效性。

Intravenous heparin in 800-1000U / h were infused for 72 hours after procedures , and oral therapy of aspirin and ticlopidine .

术后持续滴注肝素72小时，并口服阿司匹林及抵克力得。

Objective To observe the effect of combination of aspirin , ticlopidine , low molecular weight heparin ( LMWH ) in prevention of subacute stent thrombosis ( SST ) .

目的观察阿司匹林、噻氯匹啶、低分子量肝素预防亚急性冠脉支架血栓形成（SST）的效果。

CONCLUSION : Ticlopidine depresses the activation of platelets in ACI patients and reduces the damage to brain by activated platelets and prompts the resurrection of neural function .

结论：噻氯匹定能抑制急性脑梗死病人血小板的激活，减少对脑的损害，促进神经功能恢复，可用于治疗急性脑梗死。